PMID: 8946557Nov 1, 1996Paper

Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy

Reproductive Toxicology
J M MansonW P Stephenson

Abstract

Pregnancy outcomes in women with inadvertent exposure to lovastatin and simvastatin during pregnancy have been examined based on reports submitted to the manufacturer as part of worldwide postmarketing surveillance. There were 134 reports of exposure during pregnancy in which pregnancy outcome was known. Among prospectively followed pregnancies with known outcome, the proportion of normal outcomes was 85%, congenital anomalies 4.0%, spontaneous abortions 8.0%, fetal deaths/stillbirths 1.0%, and miscellaneous adverse outcomes 2.0%. While the number of prospective reports available for evaluation were only sufficient to rule out a three- to fourfold increase in the overall frequency of congenital anomalies, these proportions do not exceed what would be expected in the general population. Based on findings from this interim evaluation, there is no relationship between exposure to therapeutic doses of these agents during pregnancy and the occurrence of adverse pregnancy outcomes.

References

May 1, 1990·Australasian Radiology·R AnandS N Kaul
Jan 1, 1990·The Nurse Practitioner·A H Schultheis
Jul 7, 1988·The New England Journal of Medicine·S M Grundy
Jan 14, 1988·The New England Journal of Medicine·A Garg, S M Grundy
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A W AlbertsJ Springer
Mar 1, 1994·Clinical Obstetrics and Gynecology·W A Salameh, D S Mastrogiannis

❮ Previous
Next ❯

Citations

May 17, 2003·Birth Defects Research. Part A, Clinical and Molecular Teratology·Janine E Polifka, J M Friedman
Oct 19, 2006·Analytical and Bioanalytical Chemistry·M D HernandoA R Fernández-Alba
Mar 17, 2004·Reproductive Toxicology·S TeelucksinghS Ramsewak
Dec 29, 2010·Proceedings of the National Academy of Sciences of the United States of America·Keiichi KumasawaMasaru Okabe
Aug 19, 2004·Cardiology in Review·Shadi A QasqasUri Elkayam
Apr 7, 2012·Drugs·Edouard LecarpentierVassilis Tsatsaris
Oct 16, 2014·Seminars in Perinatology·Kirsten Lawrence ClearyMaged Costantine
Apr 22, 2015·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Tinnakorn ChaiworapongsaSonia S Hassan
Jul 21, 2012·Cardiology Clinics·Gagan Sahni
Nov 21, 2008·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Muchabayiwa GidiriEric Kilpatrick
Dec 4, 2008·Advances in Pediatrics·Jaime L Frías, Enid Gilbert-Barness
Jul 22, 2008·Reproductive Toxicology·Nobuko TaguchiShinya Ito
Nov 17, 2004·American Journal of Medical Genetics. Part a·Robin J Edison, Maximilian Muenke
Mar 3, 2009·BJOG : an International Journal of Obstetrics and Gynaecology·M ThorogoodUNKNOWN Guideline Development Group
Sep 17, 2008·American Journal of Medical Genetics. Part a·Emily E PetersenUNKNOWN National Birth Defects Prevention Study
May 20, 2011·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·L David WiseGeorge R Lankas
May 18, 2007·British Journal of Clinical Pharmacology·Benjamin OforiAnick Bérard
Dec 1, 2012·BJOG : an International Journal of Obstetrics and Gynaecology·U WinterfeldT Buclin
Feb 24, 2015·American Journal of Reproductive Immunology : AJRI·Sanmaan K BasraonRamkumar Menon
Jun 5, 2003·Expert Opinion on Pharmacotherapy·William S Webster, Jane A D Freeman
Jan 22, 2002·Best Practice & Research. Clinical Obstetrics & Gynaecology·P R James
Jul 12, 2008·Journal of the American College of Cardiology·Arie Roth, Uri Elkayam
Jul 10, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·J KramerJ Rohwedel
Sep 10, 2013·Journal of Reproductive Immunology·Guillermina Girardi
Nov 17, 2012·Biology of Reproduction·Maria E BaardmanTorsten Plösch
Dec 3, 2016·Clinical Obstetrics and Gynecology·Caroline C Marrs, Maged M Costantine
Jun 4, 2011·Therapeutic Advances in Cardiovascular Disease·Ujjaini KhanderiaThomas Boyden
Oct 27, 2004·Toxicologic Pathology·James S MacDonald, Margaretann M Halleck
Oct 4, 2012·The Annals of Pharmacotherapy·Laura M GodfreyKevin W Cleveland
Jul 30, 2004·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·George R LankasL David Wise
Sep 16, 2005·Birth Defects Research. Part A, Clinical and Molecular Teratology·Pia S PollackMichael E Stepanavage
Jan 7, 2006·Birth Defects Research. Part A, Clinical and Molecular Teratology·Anthony R Scialli
Mar 30, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·C Irl, J Hasford
Oct 20, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·June AlmenoffKarol Lacroix
Mar 7, 2012·Expert Review of Cardiovascular Therapy·D Meeike KustersBarbara A Hutten
Mar 24, 2018·Journal of Perinatal Medicine·Wanda Gajzlerska-MajewskaMiroslaw Wielgos
Jun 3, 2020·The Journal of Obstetrics and Gynaecology Research·Keiichi KumasawaTomoyuki Fujii
Jan 26, 2018·Obstetrical & Gynecological Survey·Enrique Esteve-ValverdeJaume Alijotas-Reig
Jan 1, 2009·Clinical Medicine. Cardiology·Douglas WrightOmid Salehian
Dec 31, 2020·Foods·Zvonimir PetricDanijela Bursać Kovačević
Jun 23, 2000·Journal of Inherited Metabolic Disease·J H Walter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Birth Defects Research. Part A, Clinical and Molecular Teratology
Pia S PollackMichael E Stepanavage
British Journal of Clinical Pharmacology
Benjamin OforiAnick Bérard
American Journal of Medical Genetics. Part a
Herman Gibb, Anthony R Scialli
© 2021 Meta ULC. All rights reserved